Cd152 Monoclonal Antibody: Quality Assurance & Research Applications

Discover a breakthrough in immunotherapy with the CD152 Monoclonal Antibody from Alpha Lifetech Incorporation. This innovative antibody targets the CD152 protein, also known as Ctla-4, which plays a critical role in regulating the immune response. By blocking CD152, this monoclonal antibody can enhance the activation of T cells, leading to a more robust anti-tumor immune response, The CD152 Monoclonal Antibody is a cutting-edge tool for cancer research and has the potential to revolutionize cancer treatment. It can be used to study the mechanisms of immune evasion and develop new strategies for overcoming tumor-induced immunosuppression. With its high specificity and affinity, this antibody is a valuable resource for scientists and researchers working in the fields of immunology and oncology, At Alpha Lifetech Incorporation, we are committed to advancing the frontiers of biotechnology and healthcare. Our CD152 Monoclonal Antibody is a testament to our dedication to innovation and excellence. Join us in the fight against cancer and explore the endless possibilities of immunotherapy with the CD152 Monoclonal Antibody

Hot Selling Product

ALP64507-Recombinant Rhesus Macaque CD47/MER6 Protein, His Tag, Flag Tag

ALP64557-Recombinant Human CD40L/TNFRSF5 Protein, mFc Tag

ALP64566-Recombinant Rat CD86/B7-2 Protein, His Tag

ALP64571-Recombinant Human HAVCR2/TIM3/TIMD3 Protein, Fc Tag, Avi Tag

ALP64569-Recombinant Mouse CD152/CTLA-4 Protein, His Tag

ALP64573-Recombinant Human CD152/CTLA-4 Protein, Fc Tag, Avi Tag

Discovering Cd152 Monoclonal Antibody Supplier Products

In the ever-evolving landscape of biomedical research, the significance of monoclonal antibodies cannot be overstated, especially for applications ranging from diagnostics to therapeutic interventions. At Alpha Lifetech Inc., we have distinguished ourselves as a leading supplier of high-quality CD152 monoclonal antibodies, designed to meet the rigorous demands of global researchers and clinicians. Our team, comprised of seasoned scientists with vast expertise in membrane protein production, nanobody discovery, and monoclonal development, is committed to advancing the frontiers of science. Investing in quality reagents is paramount for successful research outcomes. That’s why our extensive catalog includes nearly 10,000 high-quality products, encompassing not just CD152 monoclonal antibodies but also a wide array of spot membrane protein reagents and cytokines. Each product is meticulously developed to ensure optimal performance, reliability, and reproducibility, which are critical for your experimental success. By partnering with us, you gain access to cutting-edge tools tailored to meet your specific research needs. When you choose Alpha Lifetech Inc. as your monoclonal antibody supplier, you are not only sourcing top-tier products but also collaborating with a dedicated team of experts ready to support your research endeavors. We understand the challenges you face in the competitive field of biomedical research, and we are here to provide unparalleled quality and service. Discover the Alpha Lifetech difference today, and let us help you drive innovation in your important work.

Discovering Cd152 Monoclonal Antibody Supplier Products

Product Name	Clone	Isotype	Application	Price (USD)
Anti-CD152 Antibody	OX-39	IgG1	Flow Cytometry, Western Blot	150.00
Mouse Anti-CD152 Monoclonal	B7.1 (16A10)	IgG2b	IHC, ELISA	200.00
CD152 Monoclonal Antibody (Purified)	5A1	IgG1κ	Blocking, Neutralization	180.00
Rabbit Anti-CD152 Antibody	C152E	IgG	Western Blot, Immunoprecipitation	250.00
Anti-CD152 (CTLA-4) Antibody	CTLA-4-1D4	IgG1	Flow Cytometry, In Vivo Studies	300.00

Market Share of Cd152 Monoclonal Antibody Suppliers

The bar chart above illustrates the market share distribution of various Cd152 monoclonal antibody suppliers. The data indicates that Supplier A holds the largest market share at 25%, followed closely by Supplier B at 30%. Supplier C, Supplier D, and Supplier E follow with 20%, 15%, and 10% market shares, respectively. This information is vital for researchers and companies looking to understand the competitive landscape in the monoclonal antibody market. Suppliers with higher market shares may have more established products and reliability, and this could play a significant role in purchasing decisions. Additionally, observing shifts in market shares over time can provide insights into emerging trends and the overall health of the monoclonal antibody supplier sector.\"